Abstract
Objective: To investigate whether transdermal low dose estradiol treatment induces changes in mammographic density or heterogeneity compared to raloxifene. Secondarily, if these changes relate to changes in bone formation/resorption markers, and if these findings indicate elevation of breast cancer risk by treatment.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Menopause |
| Vol/bind | 16 |
| Udgave nummer | 4 |
| Sider (fra-til) | 785-791 |
| Antal sider | 7 |
| ISSN | 1072-3714 |
| DOI | |
| Status | Udgivet - 2009 |